PFIZER INC OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
PFIZER INC (PFE) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of -$36.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2026-08-04
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2026-06-28 was -$36.00M, a 143.90% decline year-over-year.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2026-03-29 was $60.00M, a 51.61% decline year-over-year.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2025-12-31 was -$11.00M.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2025-09-28 was -$107.00M, a 298.15% decline year-over-year.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2025 was $89.00M.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2024 was -$111.00M.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2023 was -$261.00M, a 151.99% decline from fiscal 2022.
- PFIZER INC oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2022 was $502.00M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$36.00M 10-Q · filed 2026-08-04 | $24.00M 10-Q · filed 2026-08-04 | $13.00M derived: sum of 3 quarters · filed 2026-08-04 | -$94.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $60.00M 10-Q · filed 2026-05-05 | $49.00M derived: sum of 2 quarters · filed 2026-05-05 | -$58.00M derived: sum of 3 quarters · filed 2026-05-05 | $24.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$118.00M derived: sum of 2 quarters · filed 2026-02-26 | -$36.00M derived: sum of 3 quarters · filed 2026-08-04 | $89.00M 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | -$107.00M 10-Q · filed 2025-11-04 | -$25.00M derived: sum of 2 quarters · filed 2026-08-04 | $100.00M 10-Q · filed 2025-11-04 | -$75.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $82.00M 10-Q · filed 2026-08-04 | $207.00M 10-Q · filed 2026-08-04 | $32.00M derived: sum of 3 quarters · filed 2026-08-04 | $86.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $124.00M 10-Q · filed 2026-05-05 | -$50.00M derived: sum of 2 quarters · filed 2026-05-05 | $4.00M derived: sum of 3 quarters · filed 2026-05-05 | $78.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$120.00M derived: sum of 2 quarters · filed 2026-02-26 | -$46.00M derived: sum of 3 quarters · filed 2026-02-26 | -$111.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $54.00M 10-Q · filed 2025-11-04 | $128.00M derived: sum of 2 quarters · filed 2025-11-04 | $63.00M 10-Q · filed 2025-11-04 | $213.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $74.00M 10-Q · filed 2025-08-05 | $9.00M 10-Q · filed 2025-08-05 | $159.00M derived: sum of 3 quarters · filed 2026-02-26 | $127.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$65.00M 10-Q · filed 2025-05-05 | $85.00M derived: sum of 2 quarters · filed 2026-02-26 | $53.00M derived: sum of 3 quarters · filed 2026-02-26 | $95.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $118.00M derived: sum of 2 quarters · filed 2026-02-26 | $160.00M derived: sum of 3 quarters · filed 2026-02-26 | -$261.00M 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$32.00M 10-Q · filed 2024-11-04 | $10.00M derived: sum of 2 quarters · filed 2024-11-04 | -$411.00M 10-Q · filed 2024-11-04 | $393.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $42.00M 10-Q · filed 2024-08-05 | -$379.00M 10-Q · filed 2024-08-05 | $425.00M derived: sum of 3 quarters · filed 2025-02-27 | $254.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | -$422.00M 10-Q · filed 2024-05-08 | $383.00M derived: sum of 2 quarters · filed 2025-02-27 | $212.00M derived: sum of 3 quarters · filed 2025-02-27 | -$20.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $805.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $634.00M derived: sum of 2 quarters · filed 2025-02-27 | $402.00M derived: sum of 3 quarters · filed 2025-02-27 | $502.00M 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | -$171.00M 10-Q · filed 2023-11-08 | -$403.00M derived: sum of 2 quarters · filed 2023-11-08 | -$303.00M 10-Q · filed 2023-11-08 | -$388.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | -$232.00M 10-Q · filed 2023-08-09 | -$132.00M 10-Q · filed 2023-08-09 | -$217.00M derived: sum of 3 quarters · filed 2024-02-22 | -$474.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $99.00M 10-Q · filed 2023-05-10 | $15.00M derived: sum of 2 quarters · filed 2024-02-22 | -$242.00M derived: sum of 3 quarters · filed 2024-02-22 | -$122.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$341.00M derived: sum of 2 quarters · filed 2024-02-22 | -$221.00M derived: sum of 3 quarters · filed 2024-02-22 | -$384.00M 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | -$257.00M 10-Q · filed 2022-11-09 | -$137.00M derived: sum of 2 quarters · filed 2022-11-09 | -$300.00M 10-Q · filed 2022-11-09 | -$332.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | $120.00M 10-Q · filed 2022-08-10 | -$43.00M 10-Q · filed 2022-08-10 | -$75.00M derived: sum of 3 quarters · filed 2023-02-23 | $80.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | -$163.00M 10-Q · filed 2022-05-11 | -$195.00M derived: sum of 2 quarters · filed 2023-02-23 | -$40.00M derived: sum of 3 quarters · filed 2023-02-23 | $47.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $123.00M derived: sum of 2 quarters · filed 2023-02-23 | $210.00M derived: sum of 3 quarters · filed 2023-02-23 | $173.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-27 | $155.00M 10-Q · filed 2021-11-12 | $242.00M derived: sum of 2 quarters · filed 2021-11-12 | $205.00M 10-Q · filed 2021-11-12 | $167.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-28 | $87.00M 10-Q · filed 2021-08-12 | $50.00M 10-Q · filed 2021-08-12 | $12.00M derived: sum of 3 quarters · filed 2022-02-24 | $20.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-29 | -$36.00M 10-Q · filed 2021-05-13 | -$75.00M derived: sum of 2 quarters · filed 2022-02-24 | -$67.00M derived: sum of 3 quarters · filed 2022-02-24 | -$48.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$31.00M derived: sum of 2 quarters · filed 2022-02-24 | -$12.00M derived: sum of 3 quarters · filed 2022-02-24 | $38.00M 10-K · filed 2022-02-24 | ||||
| 2019-09-29 | $8.00M 10-Q · filed 2020-11-05 | $27.00M derived: sum of 2 quarters · filed 2020-11-05 | $77.00M 10-Q · filed 2020-11-05 | $151.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $19.00M 10-Q · filed 2020-08-06 | $70.00M 10-Q · filed 2020-08-06 | $143.00M derived: sum of 3 quarters · filed 2021-02-25 | $255.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $51.00M 10-Q · filed 2020-05-07 | $124.00M derived: sum of 2 quarters · filed 2021-02-25 | $236.00M derived: sum of 3 quarters · filed 2021-02-25 | $5.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $185.00M derived: sum of 2 quarters · filed 2021-02-25 | -$46.00M derived: sum of 3 quarters · filed 2021-02-25 | -$522.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $112.00M 10-Q · filed 2019-11-07 | -$119.00M derived: sum of 2 quarters · filed 2019-11-07 | -$595.00M 10-Q · filed 2019-11-07 | -$539.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | -$231.00M 10-Q · filed 2019-08-08 | -$707.00M 10-Q · filed 2019-08-08 | -$651.00M derived: sum of 3 quarters · filed 2020-02-27 | -$545.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | -$476.00M 10-Q · filed 2019-05-09 | -$420.00M derived: sum of 2 quarters · filed 2020-02-27 | -$314.00M derived: sum of 3 quarters · filed 2020-02-27 | -$190.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $56.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $162.00M derived: sum of 2 quarters · filed 2020-02-27 | $286.00M derived: sum of 3 quarters · filed 2020-02-27 | $574.00M 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $106.00M 10-Q · filed 2018-11-08 | $230.00M derived: sum of 2 quarters · filed 2018-11-08 | $518.00M 10-Q · filed 2018-11-08 | $36.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | $124.00M 10-Q · filed 2018-08-09 | $412.00M 10-Q · filed 2018-08-09 | -$70.00M derived: sum of 3 quarters · filed 2019-02-28 | $79.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | $287.00M 10-Q · filed 2018-05-10 | -$194.00M derived: sum of 2 quarters · filed 2019-02-28 | -$45.00M derived: sum of 3 quarters · filed 2019-02-28 | $79.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$481.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$332.00M derived: sum of 2 quarters · filed 2019-02-28 | -$208.00M derived: sum of 3 quarters · filed 2019-02-28 | $130.00M 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $149.00M 10-Q · filed 2017-11-09 | $273.00M derived: sum of 2 quarters · filed 2017-11-09 | $611.00M 10-Q · filed 2017-11-09 | $250.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-07-03 | $124.00M 10-Q · filed 2017-08-10 | $463.00M 10-Q · filed 2017-08-10 | $101.00M derived: sum of 3 quarters · filed 2018-02-22 | $195.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-04-03 | $339.00M 10-Q · filed 2017-05-11 | -$23.00M derived: sum of 2 quarters · filed 2018-02-22 | $71.00M derived: sum of 3 quarters · filed 2018-02-22 | $370.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | -$362.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$268.00M derived: sum of 2 quarters · filed 2018-02-22 | $31.00M derived: sum of 3 quarters · filed 2018-02-22 | -$50.00M 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | $94.00M 10-Q · filed 2016-11-10 | $393.00M derived: sum of 2 quarters · filed 2016-11-10 | $312.00M 10-Q · filed 2016-11-10 | $164.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $299.00M 10-Q · filed 2016-08-11 | $218.00M 10-Q · filed 2016-08-11 | $70.00M derived: sum of 3 quarters · filed 2017-02-23 | -$115.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | -$81.00M 10-Q · filed 2016-05-12 | -$229.00M derived: sum of 2 quarters · filed 2017-02-23 | -$414.00M derived: sum of 3 quarters · filed 2017-02-23 | -$508.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$333.00M derived: sum of 2 quarters · filed 2017-02-23 | -$427.00M derived: sum of 3 quarters · filed 2017-02-23 | -$418.00M 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | -$185.00M 10-Q · filed 2015-11-05 | -$279.00M derived: sum of 2 quarters · filed 2015-11-05 | -$270.00M 10-Q · filed 2015-11-05 | -$419.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | -$94.00M 10-Q · filed 2015-08-06 | -$85.00M 10-Q · filed 2015-08-06 | -$234.00M derived: sum of 3 quarters · filed 2016-02-29 | $101.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | $9.00M 10-Q · filed 2015-05-07 | -$140.00M derived: sum of 2 quarters · filed 2016-02-29 | $195.00M derived: sum of 3 quarters · filed 2016-02-29 | $91.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$149.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $186.00M derived: sum of 2 quarters · filed 2016-02-29 | $82.00M derived: sum of 3 quarters · filed 2016-02-29 | -$86.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $335.00M 10-Q · filed 2014-11-06 | -$171.00M 10-Q · filed 2013-11-08 | $231.00M derived: sum of 2 quarters · filed 2014-11-06 | $63.00M 10-Q · filed 2014-11-06 | -$103.00M 10-Q · filed 2013-11-08 | $368.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | -$104.00M 10-Q · filed 2014-08-07 | $70.00M 10-Q · filed 2013-08-09 | -$272.00M 10-Q · filed 2014-08-07 | $68.00M 10-Q · filed 2013-08-09 | $33.00M derived: sum of 3 quarters · filed 2015-02-27 | $50.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | -$168.00M 10-Q · filed 2014-05-08 | -$2.00M 10-Q · filed 2013-05-10 | $137.00M derived: sum of 2 quarters · filed 2015-02-27 | $154.00M derived: sum of 3 quarters · filed 2015-02-27 | $182.00M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $305.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $322.00M derived: sum of 2 quarters · filed 2015-02-27 | $350.00M derived: sum of 3 quarters · filed 2015-02-27 | $430.00M 10-K · filed 2015-02-27 | $138.00M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $17.00M 10-Q · filed 2013-11-08 | $26.00M 10-Q · filed 2012-11-09 | $45.00M derived: sum of 2 quarters · filed 2013-11-08 | $125.00M 10-Q · filed 2013-11-08 | $151.00M 10-Q · filed 2012-11-09 | $2.00M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $28.00M 10-Q · filed 2013-08-09 | $125.00M 10-Q · filed 2013-08-09 | -$15.00M derived: sum of 3 quarters · filed 2014-02-28 | -$66.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $97.00M 10-Q · filed 2013-05-10 | -$43.00M derived: sum of 2 quarters · filed 2014-02-28 | -$94.00M derived: sum of 3 quarters · filed 2014-02-28 | -$78.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$140.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$191.00M derived: sum of 2 quarters · filed 2014-02-28 | -$175.00M derived: sum of 3 quarters · filed 2014-02-28 | -$202.00M 10-K · filed 2014-02-28 | -$128.00M 10-K · filed 2013-02-28 | |||
| 2011-10-02 | -$51.00M 10-Q · filed 2012-11-09 | -$35.00M derived: sum of 2 quarters · filed 2012-11-09 | -$62.00M 10-Q · filed 2012-11-09 | |||||
| 2011-07-03 | $16.00M 10-Q · filed 2012-08-09 | -$11.00M 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | -$134.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |